• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Emerging Technology Market
    Emerging Technology News
    Emerging Technology Stocks
    • Emerging Technology Market
    • Emerging Technology News
    • Emerging Technology Stocks
    3d printing investing

    Stratasys Ltd. Releases Q4 and Full Year 2015 Results

    Morag Mcgreevey
    Mar. 03, 2016 07:14AM PST
    Emerging Technology Investing

    Stratasys Ltd. (NASDAQ:SSYS) has announced financial results for the fourth quarter and fiscal year 2015.

    Stratasys Ltd. (NASDAQ:SSYS) has announced financial results for the fourth quarter and fiscal year 2015.
    According to the press release:

    Q4-2015 Financial Results Summary:

    • Revenue for the fourth quarter of 2015 was $173.4 million.

    • GAAP net loss for the fourth quarter was $232.3 million, or ($4.46) per diluted share, compared to a loss of $92.0 million, or ($1.81) per diluted share, for the same period last year.

    • Non-GAAP net loss for the fourth quarter was $0.7 million, or ($0.01) per diluted share, compared to non-GAAP net income of $24.9 million, or $0.48 per diluted share, reported for the same period last year.

    • The Company generated $7.7 million in cash from operations during the fourth quarter, and finished the year with approximately $258.2 million in cash and cash equivalents and short-term bank deposits.

    • The Company invested a net amount of $22.2 million in R&D projects (non-GAAP basis) during the fourth quarter, representing 12.8% of net sales.

    • Non-GAAP EBITDA for the fourth quarter amounted to a loss of $1.4 million.

    • The Company sold 4,629 3D printing and additive manufacturing systems during the quarter, and on a pro-forma combined basis, has sold a total of 146,024 systems worldwide as of December 31, 2015.

    • The Company completed the goodwill impairment analysis of all of its reporting units that began in the third quarter, and recognized an additional non-cash goodwill, and other intangible assets impairment charges of $104 million, net of tax.

    • The Company also recorded a non-cash valuation allowance against its deferred tax assets in an amount of $95 million.

    Click here to read the full press release.


     
    3d printing investingfinancial results3d printing
    The Conversation (0)

    Go Deeper

    AI Powered
    Globus Medical Reports Third Quarter 2025 Results

    Globus Medical Reports Third Quarter 2025 Results

    Bombardier Third Quarter 2025 Results See Strong Order Momentum and Significant Increases in Revenues, Deliveries, Services and Free Cash Flow

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
      • Electric Vehicles
    • Agriculture
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Energy
      • Uranium
      • Oil and Gas
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Robotics
      • Crypto
      • Cleantech
    Life Science
      • Biotech
      • Cannabis
      • Pharmaceuticals

    Featured Emerging Technology Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES